Congenital heart disease (CHD) is the most common congenital anomaly and is an
important cause of infant morbidity and mortality. Besides the epigenetic and environmental …

Genetic diseases that affect the cardiovascular system are relatively common and include
cardiac channelopathies, cardiomyopathies, aortopathies, hypercholesterolemias, and …

New discoveries using high-resolution methods for detecting genetic aberrations indicate
that the genetic contribution to congenital heart disease has been significantly …

Congenital heart disease (CHD) remains the most common birth defect, with an estimated
incidence of approximately 1% of all births. The population of adults with CHD is growing …

Genetic testing is routinely performed on infants with critical congenital heart disease (CHD).
This project reviewed the effect of implementing a genetic testing protocol in this population …

There is a growing population of adults surviving with congenital heart disease due to the
advancements in surgical repair and medical management. At the same time, the …

Objective To describe the first 3 years of experience of having an inpatient “cardiogenetics”
program which involves medical geneticist assessment of infants with major congenital heart …

Standard assessment of patients with CHD, including adult survivors, is indicated. The best
first-line genetic assessment for most patients with CHD is a chromosomal microarray, and …

The impact of congenital heart defects (CHDs) is profound. With a traditionally cited
incidence of 8 per 1000 live births (w1%), and a need for expert cardiologic intervention in 3 …

The Human Genome Project promises to revolutionize our understanding and approach to
human diseases. Specifically for congenital heart defects (CHDs), this project promises to …